Canadian Medication Cost Savings Associated with Combinatorial Pharmacogenomic Guidance for Psychiatric Medications
Julie-Anne Tanner,1,2 Lisa C Brown,3 Kunbo Yu,3 James Li,3 Bryan M Dechairo4 1Neurogenetics Section, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, University of Toronto, Department of Psychiatry, Toronto, ON, Canada; 2Assurex Health Ltd., Toronto, ON, Cana...
Saved in:
Main Authors: | Tanner JA (Author), Brown LC (Author), Yu K (Author), Li J (Author), Dechairo BM (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2019-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Use of combinatorial pharmacogenomic testing in two cases from community psychiatry
by: Fields ES, et al.
Published: (2016) -
How Pharmacogenomics Informs and Influences the Medication Experience
by: Anthony Olson, et al.
Published: (2024) -
Pharmacogenomics and Pediatric Asthmatic Medications
by: Christy Lim, et al.
Published: (2022) -
Pharmacists as facilitators of pharmacogenomic guidance for antidepressant drug selection and dosing
by: Jeffrey R. Bishop
Published: (2021) -
Prize-Distraction: A Combinatory Behavior Guidance Technique for Decreasing the Anxiety and Pain of Pediatric Dental Patients
by: Hamid Sarlak, et al.
Published: (2022)